In this context, Trabulo et al. demonstrated the development of multifunctionalized iron oxide magnetic nanoparticles (MNPs) that incorporate the anti-CD47 antibody and the chemotherapeutic drug gemcitabine for the treatment of pancreatic cancer. This evidence concerns the gene CD47 and familial pancreatic carcinoma.